Effect of Erythropoietin Administration on Myocardial Viability and Coronary Microvascular Dysfunction in Anterior Acute Myocardial Infarction: Randomized Controlled Trial in the Japanese Population

INTRODUCTION: Cardioprotective effects of erythropoietin (EPO) on infarcted myocardium in acute myocardial infarction (AMI) patients have been inconclusive. This study aimed to assess the effect of EPO administration on coronary microvascular dysfunction (CMD) and myocardial viability in anterior AM...

Descripción completa

Detalles Bibliográficos
Autores principales: Orii, Makoto, Hirata, Kumiko, Takemoto, Kazushi, Akasaka, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251819/
https://www.ncbi.nlm.nih.gov/pubmed/30353280
http://dx.doi.org/10.1007/s40119-018-0122-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251819/
https://www.ncbi.nlm.nih.gov/pubmed/30353280
http://dx.doi.org/10.1007/s40119-018-0122-1

Ejemplares similares